M. T. Labro
- Epidemiology top 5%
- Immunology top 10%
- Pharmacology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Molecular Medicine top 2%
- Co-authors
- Houria AbdelghaffarC. Babin-ChevayeA. BryskierEl Mostafa MtairagJ HakimJean‐Claude HombergMuriel AndrieuMichel Weber
- Topics
- Antibiotics Pharmacokinetics and Efficacy (17 papers)Neutrophil, Myeloperoxidase and Oxidative Mechanisms (16 papers)Antibiotic Resistance in Bacteria (15 papers)
In The Last Decade
M. T. Labro
57 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 95
- Epidemiology 505
- Immunology 386
- Pharmacology 322
- Pulmonary and Respiratory Medicine 218
- Molecular Medicine 215
Countries citing papers authored by M. T. Labro
This map shows the geographic impact of M. T. Labro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. T. Labro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. T. Labro more than expected).
Fields of papers citing papers by M. T. Labro
This network shows the impact of papers produced by M. T. Labro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. T. Labro. The network helps show where M. T. Labro may publish in the future.
Co-authorship network of co-authors of M. T. Labro
This figure shows the co-authorship network connecting the top 25 collaborators of M. T. Labro. A scholar is included among the top collaborators of M. T. Labro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. T. Labro. M. T. Labro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 6 | |
| 3 | 2 | |
| 4 | 74 | |
| 5 | 1 | |
| 6 | 43 | |
| 7 | Effect of RU004 on oxidant production by human neutrophils | 2 |
| 8 | 28 | |
| 9 | 50 | |
| 10 | 13 | |
| 11 | 7 | |
| 12 | 11 | |
| 13 | 49 | |
| 14 | 5 | |
| 15 | 7 | |
| 16 | 6 | |
| 17 | 7 | |
| 18 | 13 | |
| 19 | Interaction of cefotaxime versus desacetyl cefotaxime on human neutrophil functions. | 2 |
| 20 | 21 |
About M. T. Labro
M. T. Labro is a scholar working on Molecular Medicine, Immunology and Pharmacology, having authored 59 papers that have together received 1.3k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (17 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (16 papers) and Antibiotic Resistance in Bacteria (15 papers). The work is most often cited by research in Molecular Medicine (215 citations), Microbiology (150 citations) and Pharmacology (322 citations). M. T. Labro has collaborated with scholars based in France, Morocco and Tunisia. Frequent co-authors include Houria Abdelghaffar, C. Babin-Chevaye, A. Bryskier, El Mostafa Mtairag, J Hakim, Jean‐Claude Homberg, Muriel Andrieu, Michel Weber, Abdelaziz Soukri and Véronique Ollivier. Their work appears in journals such as The Journal of Immunology, Clinical Microbiology Reviews and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.